Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035 Corticosteroid-associated Adverse Events in Elderly Patients

被引：2

作者：

Roviello, Giandomenico ^{[1
,2
]}

Bottini, Alberto ^{[2
]}

Generali, Daniele ^{[2
,3
]}

机构：

[1] Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25124 Brescia, Italy

[2] AO Azienda Ist Ospitalieri Cremona, Unit Mol Therapy & Pharmacogen, Cremona, Italy

[3] Univ Trieste, Dept Med Surg & Hlth Sci, Piazza Ospitale, Trieste, Italy

来源：

EUROPEAN UROLOGY | 2016年 / 70卷 / 02期

关键词：

D O I：

10.1016/j.eururo.2016.05.004

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E41 / E41

页数：1

共 8 条

[1] Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035. Corticosteroid-associated Adverse Events in Elderly Patients
Fizazi, Karim
De Porre, Peter
Londhe, Anil
McGowan, Tracy
Ryan, Charles J.
[J]. EUROPEAN UROLOGY, 2016, 70 (02) : E42 - E42
[2] Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer
Fizazi, Karim
Chi, Kim N.
de Bono, Johann S.
Gomella, Leonard G.
Miller, Kurt
Rathkopf, Dana E.
Ryan, Charles J.
Scher, Howard I.
Shore, Neal D.
De Porre, Peter
Londhe, Anil
McGowan, Tracy
Pelhivanov, Nonko
Charnas, Robert
Todd, Mary B.
Montgomery, Bruce
[J]. EUROPEAN UROLOGY, 2016, 70 (03) : 438 - 444
[3] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
Roviello, Giandomenico
Generali, Daniele
Petrioli, Roberto
[J]. EUROPEAN UROLOGY, 2017, 71 (02) : E55 - E55
[4] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
van Soesta, Robert J.
de Wit, Ronald
[J]. EUROPEAN UROLOGY, 2017, 71 (01) : E9 - E10
[5] Assessment of corticosteroid (CS)-associated adverse events (AEs) with long-term (LT) exposure to low-dose prednisone (P) given with abiraterone acetate (AA) to metastatic castration-resistant prostate cancer (mCRPC) patients (Pts).
Fizazi, Karim
Chi, Kim N.
De Bono, Johann Sebastian
Gomella, Leonard G.
Miller, Kurt
Rathkopf, Dana E.
Ryan, Charles J.
Scher, Howard I.
Shore, Neal D.
De Porre, Peter
Londhe, Anil
McGowan, Tracy
Pehlivanov, Nonko
Charnas, Robert Louis
Todd, Mary Beth
Montgomery, Robert B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[6] ASSESSMENT OF CORTICOSTEROID (CS)-ASSOCIATED ADVERSE EVENTS (AES) WITH LONG-TERM (LT) EXPOSURE TO LOW-DOSE PREDNISONE (P) GIVEN WITH ABIRATERONE ACETATE (AA) TO METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS)
Gomella, Leonard G.
Chi, Kim N.
de Bono, Johann S.
Fizazi, Karim
Miller, Kurt
Rathkopf, Dana E.
Ryan, Charles J.
Scher, Howard I.
Shore, Neal D.
De Porre, Peter
Londhe, Anil
McGowan, Tracy
Pelhivanov, Nonko
Charnas, Robert
Todd, Mary B.
Montgomery, Bruce
[J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E1091 - E1091
[7] Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
de Bono, Johann
[J]. EUROPEAN UROLOGY, 2017, 71 (01) : E11 - E11
[8] Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
de Bono, Johann S.
[J]. EUROPEAN UROLOGY, 2017, 71 (02) : E56 - E56

← 1 →